FOOD ALLERGY FUND PRESENTS

ANNUAL
INNOVATION
— and —
INVESTMENT
SUMMIT

NEW YORK CITY,
APRIL 30 2025

Join us for an in-person experience, highlighting the latest advancements and cutting-edge developments in food allergy research and innovation in 2025. 

MEET THE SPEAKERS

  • Del Alfonso

    Founder & CEO
    Harmony Baby Nutrition

    Read Bio

  • Dr. Stephanie Culler

    Co-Founder & CEO
    Persephone Biosciences

    read bio
  • Dr. Huw Davies

    Dr. Huw Davies

    VP of Business Development
    Research Products and Services
    Owlstone Medical

    Read bio

  • Dr. John Fraser

    Founder & CMO
    De Motu Cordis Pty. Ltd

    Read Bio

  • Dr. Daniel Haders II, Ph.D

    CEO and Founder 
    Model Medicines

    read bio

  • Dr. Jeffery A. Hubbell

    VP Life Sciences and Engineering,
    New York University
    Lead, Initiative to Advance Engineering and Health
    Professor, Chemical and Biomolecular Engineering
    Professor, Biology
    Professor, Grossman School of Medicine
    New York University

    READ BIO

  • Dr. Nikole Kimes

    Founder & CEO
    Siolta Therapeutics

    read bio

  • Dr. Susan Lynch

    Director, Benioff Center for Microbiome Medicine 
    Professor of Medicine
    University of California San Francisco

    read bio

  • Klaus Martin

    CEO
    Nodal Therapeutics

    read bio

  • Dr. Cathryn R. Nagler

    Bunning Family Professor in the Biological Sciences Division, Pritzker School of Molecular Engineering and the College
    University of Chicago

    read bio

  • Dr. Carlotta Ronda

    Principal Investigator, Microbiome Editing Applications
    Innovative Genomics Institute

    read bio

  • Dr. Yoni Savir

    Associate Professor
    Technion – Israel Institute of Technology

    read bio

  • Ariana Thacker

    Founder & President
    MoldCo

    read bio

  • Dr. Christopher M. Warren

    Assistant Professor, Preventive Medicine (Epidemiology)
    Northwestern University

    Read bio
  • Man wearing glasses and a blue suit jacket with a light blue shirt, smiling and standing against a gray background.

    Dr. Brian Wong

    President & CEO
    RAPT Therapeutics

    Read Bio

Agenda

9:00 a.m.

Welcome Remarks: Food Allergy Fund Mission and Impact
Ilana Golant, Founder & CEO, Food Allergy Fund

9:10 a.m.

Exclusive Media Partnership Announcement

9:25 a.m.

Inaugural FAF Research Retreat Highlights: Novel Technologies & Drug Discovery
Moderator: Dr. Jeffery A. Hubbell, VP, Bioengineering Strategy, NYU Lead,
Initiative to Advance Engineering and Health; Professor, Chemical and 
Biomolecular Engineering, Biology, Grossman School of Medicine, NYU
Dr. Daniel Haders II, Founder & CEO, Model Medicines 
Dr. Carlotta Ronda, Principal Investigator, Microbiome Editing Applications,
Innovative Genomics Institute

10:00 a.m.

Visionaries in Research: Shaping the Future of Food Allergies
Dr. Susan Lynch, Director, Benioff Center for Microbiome Medicine 
Professor of Medicine, University of California San Francisco
Dr. Yoni Savir, Associate Professor, Technion – Israel Institute of Technology

10:45 a.m.

Networking Break

11:10 a.m.

Game-Changing Devices: Breath Biopsy for Microbiome Diseases & Epinephrine Inhaler
Dr. Huw Davies, VP of Business Development, Research Products and Services, Owlstone Medical
Dr. John Fraser, Founder & CMO, De Motu Cordis Pty. Ltd

11:30 a.m.

Microbiome Exposure & Implications
Del Alfonso, Founder & CEO, Harmony Baby Nutrition
Dr. Stephanie Culler, Co-Founder & CEO, Persephone Biosciences
Dr. Nikole Kimes,  Founder & CEO, Siolta Therapeutics

12:00 p.m.

Networking Lunch

1:15 p.m.

Visionaries in Research: FAF Grantee Research Highlights
Dr. Cathryn R. Nagler, Bunning Family Professor in the Biological Sciences
Division, Pritzker School of Molecular Engineering, University of Chicago
Dr. Christopher M. Warren, Assistant Professor, Preventive Medicine
Epidemiology, Northwestern University

1:35 p.m.

Immuno-Modulators: Driving the Future of Immune System Therapy
Klaus Martin, CEO, Nodal Therapeutics
Ariana Thacker, Founder & President, MoldCo
Dr. Brian Wong, President & CEO, RAPT Therapeutics

2:05 p.m.

Closing Remarks & Networking Session